Nifty

:

23622.90

Sensex

:

75527.95

461.30 (1.99%)
1695.40 (2.30%)

Login

Nifty
Sensex

:
:

23622.90
75527.95

461.30 (1.99%)
1695.40 (2.30%)

Gufic Biosciences Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

67/99

BSE: 509079 | NSE: GUFICBIO

Watchlist

NSE BSE

371.25

12-Jun-2026

Open
High
Low
Previous Close

355.2
374.9
352.6
353.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

161321
58797762.55
407.85
268

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,723.49
57.98
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,032.44
0.03%
5.60

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.03
10.95
5.88

EBITDA CAGR (%)

10 Years
5 Years
3 Years

21.35
10.20
0.26

PAT CAGR (%)

10 Years
5 Years
3 Years

25.32
9.59
-4.27

P:E (Median)

8 Years
5 Years
3 Years

52.35
52.35
52.35

P:BV (Average)

8 Years
5 Years
3 Years

4.95
4.95
4.95

EV:EBITDA (Average)

8 Years
5 Years
3 Years

22.65
22.65
22.65

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 252.05 205.02 22.94% 231.09 207.79 11.21% 230.42 204.18 12.85% 226.91 202.81 11.88%
Expenses 206.14 178.38 15.56% 194.79 173.85 12.04% 194.62 165.56 17.55% 194.58 167.03 16.49%
EBITDA 45.91 26.64 72.33% 36.31 33.94 6.98% 35.79 38.62 -7.33% 32.33 35.78 -9.64%
EBIDTM 18.21% 12.99% 15.71% 16.33% 15.53% 18.92% 14.25% 17.64%
Other Income -1.20 0.38 - 0.79 1.86 -57.53% 2.09 0.11 1,800.00% 0.89 1.26 -29.37%
Interest 9.44 8.40 12.38% 8.36 4.91 70.26% 9.58 5.18 84.94% 9.23 4.62 99.78%
Depreciation 7.65 7.84 -2.42% 7.69 4.62 66.45% 7.77 4.30 80.70% 7.72 4.30 79.53%
PBT 27.63 10.78 156.31% 21.05 26.28 -19.90% 20.53 29.26 -29.84% 16.28 28.11 -42.08%
Tax 7.05 2.81 150.89% 5.49 6.96 -21.12% 5.59 7.48 -25.27% 4.20 7.25 -42.07%
PAT 20.58 7.97 158.22% 15.56 19.32 -19.46% 14.93 21.78 -31.45% 12.07 20.86 -42.14%
PATM 8.16% 3.89% 6.73% 9.30% 6.48% 10.67% 5.32% 10.28%
EPS 2.05 0.80 156.25% 1.55 1.93 -19.69% 1.49 2.17 -31.34% 1.20 2.08 -42.31%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 251.82 205.02 22.83% 231.41 207.79 11.37% 237.05 204.18 16.10% 223.72 202.81 10.31%
Expenses 204.61 178.65 14.53% 198.43 173.87 14.13% 199.21 165.56 20.32% 190.42 167.03 14.00%
EBITDA 47.21 26.37 79.03% 32.98 33.92 -2.77% 37.84 38.62 -2.02% 33.30 35.78 -6.93%
EBIDTM 18.75% 12.86% 14.25% 16.33% 15.96% 18.91% 14.89% 17.64%
Other Income -1.17 0.39 - 0.79 1.86 -57.53% 2.12 0.11 1,827.27% 0.93 1.26 -26.19%
Interest 9.44 8.40 12.38% 8.36 4.91 70.26% 9.58 5.18 84.94% 9.23 4.62 99.78%
Depreciation 7.65 7.84 -2.42% 7.69 4.62 66.45% 7.77 4.30 80.70% 7.72 4.30 79.53%
PBT 28.95 10.53 174.93% 17.72 26.26 -32.52% 22.60 29.25 -22.74% 17.27 28.11 -38.56%
Tax 7.05 2.81 150.89% 5.30 6.96 -23.85% 5.78 7.48 -22.73% 4.20 7.25 -42.07%
PAT 21.90 7.72 183.68% 12.42 19.31 -35.68% 16.82 21.77 -22.74% 13.07 20.86 -37.34%
PATM 8.70% 3.77% 5.37% 9.29% 7.10% 10.66% 5.84% 10.28%
EPS 2.18 0.77 183.12% 1.24 1.93 -35.75% 1.68 2.17 -22.58% 1.30 2.08 -37.50%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 940.47 819.81 806.67 690.62 779.16 487.70 378.84 350.77 305.58 245.52 202.20 Net Sales Growth 14.72% 1.63% 16.80% -11.36% 59.76% 28.74% 8.00% 14.79% 24.46% 21.42% Cost Of Goods Sold 421.19 309.97 339.06 295.46 368.49 226.12 156.47 161.37 128.58 107.42 90.84 Gross Profit 519.28 509.84 467.60 395.16 410.67 261.58 222.37 189.40 177.01 138.10 111.35 GP Margin 55.21% 62.19% 57.97% 57.22% 52.71% 53.64% 58.70% 54.00% 57.93% 56.25% 55.07% Total Expenditure 790.13 683.41 659.37 555.97 631.13 403.78 326.72 304.78 266.80 222.57 182.51 Power & Fuel Cost - 18.46 17.61 15.24 11.00 9.94 8.23 3.43 3.58 3.51 3.57 % Of Sales - 2.25% 2.18% 2.21% 1.41% 2.04% 2.17% 0.98% 1.17% 1.43% 1.77% Employee Cost - 127.19 109.67 86.73 85.61 66.22 58.59 46.85 44.62 41.03 31.95 % Of Sales - 15.51% 13.60% 12.56% 10.99% 13.58% 15.47% 13.36% 14.60% 16.71% 15.80% Manufacturing Exp. - 106.44 89.75 72.21 82.20 46.74 43.26 43.16 37.69 28.94 23.54 % Of Sales - 12.98% 11.13% 10.46% 10.55% 9.58% 11.42% 12.30% 12.33% 11.79% 11.64% General & Admin Exp. - 61.77 54.18 44.70 37.97 23.69 32.47 32.32 31.50 27.03 20.56 % Of Sales - 7.53% 6.72% 6.47% 4.87% 4.86% 8.57% 9.21% 10.31% 11.01% 10.17% Selling & Distn. Exp. - 47.57 40.20 31.74 28.38 17.87 17.35 11.36 13.26 9.11 8.19 % Of Sales - 5.80% 4.98% 4.60% 3.64% 3.66% 4.58% 3.24% 4.34% 3.71% 4.05% Miscellaneous Exp. - 12.03 8.89 9.88 17.48 13.20 10.36 6.29 7.57 5.53 8.19 % Of Sales - 1.47% 1.10% 1.43% 2.24% 2.71% 2.73% 1.79% 2.48% 2.25% 1.90% EBITDA 150.34 136.40 147.30 134.65 148.03 83.92 52.12 45.99 38.78 22.95 19.69 EBITDA Margin 15.99% 16.64% 18.26% 19.50% 19.00% 17.21% 13.76% 13.11% 12.69% 9.35% 9.74% Other Income 2.57 3.62 2.18 2.57 3.10 3.73 5.79 4.17 2.86 1.44 0.66 Interest 36.61 24.52 16.79 8.22 5.37 13.63 13.91 10.16 8.88 6.34 6.20 Depreciation 30.83 21.06 17.02 22.28 18.93 16.31 13.86 4.65 4.40 3.68 3.79 PBT 85.49 94.43 115.67 106.72 126.84 57.71 30.13 35.35 28.37 14.37 10.36 Tax 22.33 24.49 29.54 27.02 31.00 13.48 7.44 13.41 13.48 5.35 3.03 Tax Rate 26.12% 25.93% 25.54% 25.32% 24.44% 23.36% 24.69% 37.93% 44.99% 37.23% 29.25% PAT 63.14 69.93 86.14 79.70 95.84 44.23 22.69 21.94 16.48 9.02 7.32 PAT before Minority Interest 63.14 69.93 86.14 79.70 95.84 44.23 22.69 21.94 16.48 9.02 7.32 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.71% 8.53% 10.68% 11.54% 12.30% 9.07% 5.99% 6.25% 5.39% 3.67% 3.62% PAT Growth -9.71% -18.82% 8.08% -16.84% 116.69% 94.93% 3.42% 33.13% 82.71% 23.22% EPS 6.30 6.97 8.59 7.95 9.56 4.41 2.26 2.19 1.64 0.90 0.73

Description TTM Mar 25 Mar 24
Net Sales 944.00 819.81 806.67 Net Sales Growth 15.15% 1.63% Cost Of Goods Sold 421.17 309.97 339.06 Gross Profit 522.83 509.84 467.60 GP Margin 55.38% 62.19% 57.97% Total Expenditure 792.67 683.71 659.37 Power & Fuel Cost - 18.46 17.61 % Of Sales - 2.25% 2.18% Employee Cost - 127.19 109.67 % Of Sales - 15.51% 13.60% Manufacturing Exp. - 106.44 89.75 % Of Sales - 12.98% 11.13% General & Admin Exp. - 62.06 54.18 % Of Sales - 7.57% 6.72% Selling & Distn. Exp. - 47.57 40.20 % Of Sales - 5.80% 4.98% Miscellaneous Exp. - 12.04 8.89 % Of Sales - 1.47% 1.10% EBITDA 151.33 136.10 147.30 EBITDA Margin 16.03% 16.60% 18.26% Other Income 2.67 3.63 2.18 Interest 36.61 24.52 16.79 Depreciation 30.83 21.06 17.02 PBT 86.54 94.14 115.67 Tax 22.33 24.49 29.54 Tax Rate 25.80% 26.01% 25.54% PAT 64.21 69.65 86.14 PAT before Minority Interest 64.21 69.65 86.14 Minority Interest 0.00 0.00 0.00 PAT Margin 6.80% 8.50% 10.68% PAT Growth -7.82% -19.14% EPS 6.40 6.94 8.59

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 601.36 532.56 347.81 269.12 173.44 129.32 75.35 54.14 37.33 33.96 Share Capital 10.03 10.03 9.69 9.69 9.69 9.69 7.78 7.78 7.74 7.74 Total Reserves 591.23 522.53 338.11 259.42 163.74 119.63 67.56 46.35 29.59 26.22 Non-Current Liabilities 180.73 187.93 224.18 65.88 54.96 37.79 17.16 12.54 9.16 14.56 Secured Loans 130.50 153.96 190.68 47.98 35.43 19.52 11.25 4.43 3.20 4.84 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.03 0.06 3.89 3.42 2.82 Long Term Provisions 17.49 15.38 13.29 12.39 10.23 7.93 1.86 2.26 2.29 1.39 Current Liabilities 387.53 372.05 288.21 186.40 190.96 239.77 217.72 168.55 128.18 103.68 Trade Payables 158.75 166.27 130.26 140.95 111.21 117.07 77.81 75.98 43.74 52.62 Other Current Liabilities 70.14 56.48 38.82 33.30 29.98 22.99 16.28 17.24 20.75 14.10 Short Term Borrowings 154.27 142.02 111.76 6.60 16.32 93.10 84.69 69.17 46.97 32.28 Short Term Provisions 4.38 7.28 7.37 5.55 33.45 6.62 38.95 6.16 16.73 4.67 Total Liabilities 1,169.62 1,092.54 860.20 521.40 419.36 406.88 310.23 235.23 174.67 152.20 Net Block 505.99 158.89 159.57 115.17 99.97 82.58 24.45 22.85 21.96 22.15 Gross Block 614.12 246.23 246.28 179.65 148.64 114.98 37.19 31.00 25.65 51.31 Accumulated Depreciation 108.13 87.34 86.71 64.48 48.67 32.40 12.74 8.15 3.68 29.17 Non Current Assets 545.85 492.07 396.08 200.65 131.48 133.58 46.34 37.02 31.42 32.69 Capital Work in Progress 21.82 307.06 169.59 40.87 13.40 30.61 9.63 2.05 0.04 0.00 Non Current Investment 2.81 1.79 0.78 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Long Term Loans & Adv. 13.17 23.12 64.35 43.65 17.12 18.54 10.16 8.73 7.60 9.01 Other Non Current Assets 2.06 1.21 1.80 0.95 0.98 1.84 2.09 3.38 1.82 1.52 Current Assets 623.78 600.47 464.11 320.75 287.88 273.31 263.89 198.20 143.25 119.51 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 216.87 200.48 183.46 115.57 94.40 122.46 94.28 94.20 63.02 50.26 Sundry Debtors 314.61 329.94 205.47 151.55 124.50 106.97 103.18 80.80 52.12 56.23 Cash & Bank 28.21 13.47 46.69 26.57 13.18 16.37 7.59 7.50 5.64 6.16 Other Current Assets 64.09 3.75 1.79 0.86 55.80 27.50 58.84 15.70 22.47 6.86 Short Term Loans & Adv. 62.52 52.83 26.71 26.21 55.11 26.71 57.95 15.53 22.30 6.55 Net Current Assets 236.24 228.42 175.90 134.35 96.92 33.53 46.17 29.66 15.07 15.84 Total Assets 1,169.63 1,092.54 860.19 521.40 419.36 406.89 310.23 235.22 174.67 152.20

Description Mar 25 Mar 24
Shareholder's Funds 601.08 532.56 Share Capital 10.03 10.03 Total Reserves 590.94 522.53 Non-Current Liabilities 180.73 187.93 Secured Loans 130.50 153.96 Unsecured Loans 0.00 0.00 Long Term Provisions 17.49 15.38 Current Liabilities 387.56 372.05 Trade Payables 158.75 166.27 Other Current Liabilities 70.14 56.48 Short Term Borrowings 154.27 142.02 Short Term Provisions 4.40 7.28 Total Liabilities 1,169.37 1,092.54 Net Block 505.99 158.89 Gross Block 614.12 246.23 Accumulated Depreciation 108.13 87.34 Non Current Assets 544.84 492.06 Capital Work in Progress 21.82 307.06 Non Current Investment 1.78 1.78 Long Term Loans & Adv. 13.18 23.12 Other Non Current Assets 2.06 1.21 Current Assets 624.52 600.48 Current Investments 0.00 0.00 Inventories 216.87 200.48 Sundry Debtors 314.61 329.94 Cash & Bank 29.02 13.48 Other Current Assets 64.02 3.75 Short Term Loans & Adv. 62.52 52.83 Net Current Assets 236.97 228.43 Total Assets 1,169.36 1,092.54

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 122.78 -7.46 -26.59 106.24 87.25 47.10 5.21 -4.82 -4.13 -4.32 PBT 94.43 115.67 106.72 126.84 57.71 30.13 35.35 29.95 14.37 11.19 Adjustment 43.79 34.15 29.64 23.18 30.79 24.63 13.35 12.07 9.75 8.84 Changes in Working Capital 7.37 -130.23 -135.25 -10.72 8.15 2.48 -33.52 -30.40 -23.70 -21.31 Cash after chg. in Working capital 145.59 19.59 1.11 139.30 96.65 57.24 15.18 11.63 0.42 -1.28 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -22.81 -27.04 -27.70 -33.06 -9.40 -10.14 -9.98 -16.44 -4.55 -2.65 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 Cash From Investing Activity -71.79 -102.40 -190.73 -94.59 -6.69 -42.53 -12.99 -8.84 -4.69 -0.51 Net Fixed Assets -82.65 -137.42 -195.35 -58.48 -16.45 -98.77 -13.77 -7.36 25.62 -0.50 Net Investments -1.02 -1.01 -0.77 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 11.88 36.03 5.39 -36.11 9.76 56.24 0.78 -1.48 -30.31 -0.01 Cash from Financing Activity -37.20 82.38 234.31 -6.24 -78.62 -4.21 7.71 14.40 7.41 4.78 Net Cash Inflow / Outflow 13.78 -27.48 16.99 5.41 1.94 0.37 -0.08 0.75 -1.41 -0.05 Opening Cash & Equivalents 1.13 28.60 11.61 6.20 4.26 3.90 3.74 2.99 4.28 6.21 Closing Cash & Equivalent 14.91 1.13 28.60 11.61 6.20 4.26 3.66 3.74 2.87 6.16

Description Mar 25 Mar 24
Cash From Operating Activity 122.57 -7.46 PBT 94.14 115.67 Adjustment 43.79 34.15 Changes in Working Capital 7.44 -130.23 Cash after chg. in Working capital 145.38 19.59 Interest Paid 0.00 0.00 Tax Paid -22.81 -27.04 Other Direct Exp. Paid 0.00 0.00 Extra & Other Items 0.00 0.00 Cash From Investing Activity -70.78 -102.39 Net Fixed Assets -82.65 Net Investments -1.02 Others 12.89 Cash from Financing Activity -37.20 82.38 Net Cash Inflow / Outflow 14.59 -27.46 Opening Cash & Equivalents 1.14 28.60 Closing Cash & Equivalent 15.72 1.14

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 59.96 53.11 35.88 27.76 17.89 13.34 9.68 6.96 4.83 4.39 ROA 6.18% 8.82% 11.54% 20.98% 10.00% 5.65% 8.04% 8.04% 5.52% 5.24% ROE 12.34% 19.57% 25.84% 43.31% 29.22% 22.17% 33.89% 36.03% 25.31% 23.99% ROCE 13.51% 17.56% 23.23% 47.29% 30.05% 21.01% 29.65% 34.10% 24.26% 24.24% Fixed Asset Turnover 2.56 3.82 3.76 5.17 3.94 5.14 10.57 11.21 6.77 4.19 Receivable days 106.89 103.93 81.36 59.40 81.43 97.98 93.16 76.39 75.93 76.38 Inventory Days 69.22 74.53 68.14 45.18 76.30 101.05 95.44 90.36 79.39 74.21 Payable days 191.37 159.61 167.52 124.89 184.25 115.05 115.32 80.93 87.99 110.87 Cash Conversion Cycle -15.25 18.85 -18.02 -20.30 -26.52 83.98 73.27 85.82 67.32 39.73 Total Debt/Equity 0.52 0.60 0.90 0.23 0.32 0.90 1.30 1.47 1.52 1.26 Interest Cover 4.85 7.89 13.98 24.64 5.23 3.17 4.48 4.37 3.27 2.67

Description Mar 25 Mar 24
Book Value (Rs.) 59.93 53.11 ROA 6.16% 7.88% ROE 12.29% 16.17% ROCE 13.48% 15.59% Fixed Asset Turnover 2.56 3.82 Receivable days 106.89 128.09 Inventory Days 69.22 77.83 Payable days 191.37 178.99 Cash Conversion Cycle -15.25 26.94 Total Debt/Equity 0.52 0.60 Interest Cover 4.84 7.89

Top Investors:

motilal oswal financial services limited

icici prudential multicap fund

jagdish n master

investor education and protection fund (iepf)

Annual Reports:

News Update:

Gufic Biosciences gets nod to make further investment in Saraswat Co-operative Bank
30th May 2026, 14:13 PM

The Board of Directors of the Company at its meeting held on May 29, 2026, has approved the same
Read More
Gufic Biosciences makes investment of $50,000 in Selvax
29th Apr 2026, 16:44 PM

Total number of Ordinary shares held after post-acquisition is 16,85,350 shares
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback